Black Diamond Therapeutics Inc
BDTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$109.45M
Close$
$6.37
242.3% upside
Current Fair Value
242.3% upsideUndervalued by 242.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $109.45 Million |
|---|---|
| Enterprise Value | $93.46 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.39 |
| Beta | 3.25 |
| Outstanding Shares | 57,233,413 |
Return
| Return on Equity | -41.43% |
|---|---|
| Return on Assets | -32.51% |
| Return on Invested Capital | -38.79% |
Valuation & Multiples
| P/E Ratio | -2.51 |
|---|---|
| PEG | 2.17 |
| Price to Sales | - |
| Price to Book Ratio | 1.86 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -2.04 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.18
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.8203▲ 139.73% |
|---|---|
| Total Calls | 56,200▼ 75.39% |
| Total Puts | 102,300▲ 5.90% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 67.46%▲ 0.64% |
|---|---|
| Total Invested | $82.03M▼ 10.86% |
| Investors Holding | 108▼ 2.00% |
ESG Score
No data